Medicine formula for conditioning urinary system and preparation process thereof

Through a drug formula containing a variety of Chinese medicine ingredients and a method of moxa stick moxibustion treatment, the problem of poor efficacy in the treatment of urinary diseases in the prior art has been solved, and better therapeutic effects and fewer negative physical effects have been achieved.

CN120168596AInactive Publication Date: 2025-06-20YIWUTANG HEALTH TECHNOLOGY (XIAN) CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202510503329.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2025-04-22
Publication Date
2025-06-20
Estimated Expiration
Not applicable · inactive patent

AI Technical Summary

Technical Problem

The prior art has poor therapeutic effects when treating urinary diseases and cannot effectively deal with the treatment needs of the initial stages of the disease, and drugs may have a negative impact on physical health.

Method used

A drug formula for regulating the urinary system is adopted, including angelica, peach kernel, bacon, curcuma zedo, peony bark, poria cocos, summer trunk, acne twig, cinnamon twig, fried king trunk, turtle, borneol, musk and mugwort leaves, etc., and the medicine is mixed into powder through a specific preparation process, and moxa sticks are moxibusted to treat acupoints to improve the efficacy of the medicine.

Benefits of technology

This drug formula can effectively prevent inflammation and analgesic, promote blood circulation and remove blood stasis, regulate various urinary diseases, improve treatment effects, and reduce negative impacts on the body.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The medicine formula for conditioning the urinary system is characterized by comprising the following raw materials in parts by weight: Chinese angelica, moutan bark, 8-12 parts of peach kernel, 1-5 parts of stir-baked squama manitis, curcuma zedoary, poria cocos, 8-12 parts of selfheal, 7-11 parts of radix achyranthis bidentatae, 8-14 parts of rhizoma sparganii, 4-10 parts of cassia twig, 8-15 parts of fried cowherb seed, 8-12 parts of ground beetle and 8-13 parts of borneol. 1-5 parts by weight of musk and 17-25 parts by weight of folium artemisiae argyi; the invention relates to a preparation process of a medicine for conditioning a urinary system. The preparation process comprises the following steps: step 1, screening folium artemisiae argyi, and finely crushing the folium artemisiae argyi into cotton fibers; step 2, sieving the cotton-shaped folium artemisiae argyi obtained in the step 1 to obtain moxa; step 3, screening the medicines, and grinding and mixing the medicines into medicine powder; 4, fully mixing the moxa in the step 2 and the medicine powder in the step 3, and wrapping and fixing by using mulberry bark. The traditional Chinese medicine composition has the beneficial effects that the initial stage of diseases can be effectively treated, and the overall treatment effect is improved.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of traditional Chinese medicine, and particularly relates to a drug formula for conditioning the urinary system and its preparation process. Background Art

[0002] With the improvement of living standards, the richness of food quality that can be contacted in daily life has been greatly improved. At the same time, due to excessive pressure in life and work, some gynecological diseases in the urinary system are caused. In most cases, such gynecological diseases do not directly affect normal life and work. Often, the symptoms will break out after a long-term accumulation, thus seriously affecting people's normal life. In the early stage of recuperation of such diseases, drugs with too strong efficacy are not used. On the one hand, the relevant treatment costs are relatively high. On the other hand, such drugs will also more or less affect physical health. Therefore, it is impossible to carry out sufficient and effective treatment at the initial stage of the disease condition, and the corresponding use requirements cannot be met. Summary of the Invention

[0003] The purpose of the present invention is to provide a drug formula for conditioning the urinary system and its preparation process, which solves the technical problem of poor treatment effect in the prior art and inability to handle the treatment at the initial stage of the disease condition, and realizes the technical effect of improving the overall treatment effect and properly handling the initial stage of the disease condition.

[0004] In order to achieve the above-mentioned invention purpose, the technical solution adopted by the present invention is as follows:

[0005] A drug formula for conditioning the urinary system, comprising the following raw materials in parts by weight: 8 to 12 parts by weight of Angelica sinensis, 8 to 12 parts by weight of peach kernels, 1 to 5 parts by weight of pangolin scales, 8 to 12 parts by weight of zedoary, 8 to 12 parts by weight of cortex moutan, 8 to 12 parts by weight of poria cocos, 8 to 12 parts by weight of prunella vulgaris, 7 to 11 parts by weight of achyranthes bidentata, 8 to 14 parts by weight of sparganium, 4 to 10 parts by weight of cassia twig, 8 to 15 parts by weight of stir-fried semen vaccariae, 8 to 12 parts by weight of ground beetle, 8 to 13 parts by weight of borneol, 1 to 5 parts by weight of moschus, 17 to 25 parts by weight of artemisia argyi.

[0006] Preferably, it comprises the following raw materials in parts by weight: 9 to 11 parts by weight of Angelica sinensis, 9 to 11 parts by weight of peach kernels, 2 to 4 parts by weight of pangolin scales, 9 to 11 parts by weight of zedoary, 9 to 11 parts by weight of cortex moutan, 9 to 11 parts by weight of poria cocos, 9 to 11 parts by weight of prunella vulgaris, 8 to 10 parts by weight of achyranthes bidentata, 9 to 11 parts by weight of sparganium, 5 to 8 parts by weight of cassia twig, 9 to 13 parts by weight of stir-fried semen vaccariae, 9 to 11 parts by weight of ground beetle, 9 to 11 parts by weight of borneol, 2 to 4 parts by weight of moschus, 19 to 23 parts by weight of artemisia argyi.

[0007] A preparation process of a drug for regulating the urinary system, comprising the following steps: Step 1: Screen Artemisia argyi, and after removing impurities, thick stems and dust, place it in a stone trough and beat and grind it until it is broken into cotton-like flakes;

[0008] Step 2: Sieve the cotton-like Artemisia argyi in Step 1 to obtain moxa floss;

[0009] Step 3: Sieve and grind Angelica sinensis, Prunus persica, Squama Manis, Rhizoma Curcumae, Cortex Moutan, Poria cocos, Spica Prunellae, Achyranthes bidentata, Rhizoma Sparganii, Ramulus Cinnamomi, Semen Vaccariae, Eupolyphaga seu Steleophaga, Borneolum Syntheticum, Moschus, etc. and mix them into a medicinal powder;

[0010] Step 4: Thoroughly mix the moxa floss in Step 2 with the medicinal powder in Step 3, then add an adhesive and stir and mix well. After completing the stirring and mixing, roll it into a cylindrical shape through a press and use mulberry bark to wrap and fix it.

[0011] As an improvement, the time for beating and grinding in Step 1 is 20 minutes, and the beating speed is 65 to 70 times per minute. The sieving process in Step 2 requires a 150-mesh sieve.

[0012] As an improvement, each raw material in Step 3 needs to be washed and dried. After completing the preparation of the medicinal powder, the overall moisture content needs to be less than 5%.

[0013] As an improvement, the stirring and mixing step in Step 4 needs to be combined with a heating device to maintain the temperature in the mixing and stirring device at 50°C, so as to increase the temperature of the adhesive and avoid sticking and cooling and caking with the medicinal powder.

[0014] The beneficial effects of the present invention are as follows: By configuring drugs such as Angelica sinensis, Prunus persica, and Squama Manis, it can effectively reduce inflammation and relieve pain, activate blood circulation and remove blood stasis, and can regulate diseases such as gynecological inflammation, cervical erosion, turning HPV positive to negative, cervicitis, pelvic effusion, uterine fibroids, cold uterus, frequent urination, urgency, dysuria, urinary incontinence, urinary retention, bacteriuria, pyuria, hematuria, oliguria or anuria, dysmenorrhea, amenorrhea, low back pain, urinary system infection, urinary system tumors, etc., and can reduce the negative impact on the body while effectively treating. Detailed Description of the Invention

[0015] The various exemplary embodiments of the present invention will now be described in detail. This detailed description should not be considered as a limitation of the present invention, but should be understood as a more detailed description of certain aspects, characteristics and implementation schemes of the present invention.

[0016] It should be understood that the terms used in the present invention are only for describing particular embodiments and are not intended to limit the present invention. Additionally, for the numerical ranges in the present invention, it should be understood that each intermediate value between the upper and lower limits of the range is also specifically disclosed. Each intermediate value within any stated value or stated range, as well as each smaller range between any other stated value or intermediate value within the stated range, is also included in the present invention. The upper and lower limits of these smaller ranges may be independently included or excluded from the range.

[0017] Unless otherwise specified, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the present invention pertains. Although the present invention only describes preferred methods and materials, any methods and materials similar or equivalent to those described herein may also be used in the practice or testing of the present invention. All documents mentioned in this specification are incorporated by reference to disclose and describe the methods and materials related to the documents. In case of conflict with any incorporated document, the content of this specification shall prevail.

[0018] A pharmaceutical formulation for conditioning the urinary system, comprising the following raw materials in parts by weight: 8 to 12 parts by weight of Angelica sinensis, 8 to 12 parts by weight of peach kernels, 1 to 5 parts by weight of fried pangolin scales, 8 to 12 parts by weight of zedoary, 8 to 12 parts by weight of moutan bark, 8 to 12 parts by weight of poria, 8 to 12 parts by weight of selfheal spike, 7 to 11 parts by weight of achyranthes root, 8 to 14 parts by weight of rhizoma sparganii, 4 to 10 parts by weight of cassia twig, 8 to 15 parts by weight of stir-fried semen vaccariae, 8 to 12 parts by weight of ground beetle, 8 to 13 parts by weight of borneol, 1 to 5 parts by weight of moschus, 17 to 25 parts by weight of mugwort leaf.

[0019] When in use, the optimal parts by weight for use are: 9 to 11 parts by weight of Angelica sinensis, 9 to 11 parts by weight of peach kernels, 2 to 4 parts by weight of fried pangolin scales, 9 to 11 parts by weight of zedoary, 9 to 11 parts by weight of moutan bark, 9 to 11 parts by weight of poria, 9 to 11 parts by weight of selfheal spike, 8 to 10 parts by weight of achyranthes root, 9 to 11 parts by weight of rhizoma sparganii, 5 to 8 parts by weight of cassia twig, 9 to 13 parts by weight of stir-fried semen vaccariae, 9 to 11 parts by weight of ground beetle, 9 to 11 parts by weight of borneol, 2 to 4 parts by weight of moschus, 19 to 23 parts by weight of mugwort leaf. Among them, the optimal ratio of Angelica sinensis, peach kernels and mugwort leaf is 1:1:2.

[0020] A preparation process for a medicine for regulating the urinary system comprises the following steps: step 1, screening wormwood leaves, after removing impurities, thick stems and dust, placing in a stone trough, beating and grinding, so that it is finely broken into cotton wool; step 2, sieving the cotton wool-like wormwood leaves of step 1 to obtain wormwood wool; step 3, sieving and grinding angelica sinensis, peach kernel, stir-fried pangolin, zedoaria, peony bark, Poria cocos, selfheal, Achyranthes bidentata, Tripterygium wilfordii, cassia twig, stir-fried cycads, Eupolyphaga sinensis, Borneolum, musk, and mixing into powder; step 4, fully mixing the wormwood wool in step 2 with the powder in step 3, then adding an adhesive and stirring and mixing, rolling into a cylindrical shape by a plodder after stirring and mixing, and wrapping and fixing with mulberry bark. When wrapping with mulberry bark, an adhesive can be applied on the inside of the mulberry bark to further improve the fixing effect of the internal powder. After the preparation is completed, it can be heated and dried, and then sealed and protected with a plastic film or waterproof paper.

[0021] The time of beating and grinding in step 1 is 20 minutes, and the speed of beating is 65 to 70 times per minute. The screening process in step 2 needs to use a 150-mesh screen. In step 3, each raw material needs to be cleaned and dried. After the preparation of the powder is completed, the overall moisture content needs to be less than 5%. In step 4, the stirring and mixing step needs to be coordinated with a heating device to maintain the temperature in the mixing and stirring device at 50°C to increase the temperature of the adhesive and avoid cooling and agglomeration with the powder. In the process of preparing the powder, if the water content is too high, the raw materials can be fried or dried to ensure the moisture content requirement of the final powder.

[0022] How to use moxa sticks: Select acupuncture points such as Zhongwan, Shenque, Liangmen, Zusanli, and Weishu, light the moxibustion stick, aim it at the acupuncture points, and moxibustion until you feel warm and comfortable, and moxibustion until the skin flushes. Generally, each acupuncture point should be moxibustioned for 12 to 15 minutes, alternating once a day, two weeks as a course of treatment, and observe the efficacy after two courses of treatment. During use, after lighting the moxa stick, place it 5 to 10 cm away from the acupuncture point, and perform hot moxibustion through heat. The moxibustion stick can be wrapped around the acupuncture point for massage, or the moxibustion stick can be directly pressed against the acupuncture point and then removed after three seconds. When performing moxibustion with moxa sticks, you need to pay attention to flicking the moxa ash in time to avoid scalding the skin.

[0023] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention shall be included in the protection scope of the present invention.

Claims

1. A pharmaceutical formulation for regulating the urinary system, characterized in that: The invention comprises the following raw materials in parts by weight: 8 to 12 parts by weight of angelica sinensis, 8 to 12 parts by weight of peach kernel, 1 to 5 parts by weight of roasted pangolin, 8 to 12 parts by weight of zedoaria, 8 to 12 parts by weight of moutan bark, 8 to 12 parts by weight of tuckahoe, 8 to 12 parts by weight of selfheal, 7 to 11 parts by weight of achyranthes bidentata, 8 to 14 parts by weight of trigonosciadium japonicum, 4 to 10 parts by weight of cassia twig, 8 to 15 parts by weight of stir-fried cyperus rotundus, 8 to 12 parts by weight of earthworm, 8 to 13 parts by weight of borneol, 1 to 5 parts by weight of musk, and 17 to 25 parts by weight of wormwood.

2. A pharmaceutical formulation for regulating the urinary system according to claim 1, characterized in that: The invention comprises the following raw materials in parts by weight: 9 to 11 parts by weight of angelica sinensis, 9 to 11 parts by weight of peach kernel, 2 to 4 parts by weight of roasted pangolin, 9 to 11 parts by weight of zedoaria zedoaria, 9 to 11 parts by weight of moutan bark, 9 to 11 parts by weight of tuckahoe, 9 to 11 parts by weight of selfheal, 8 to 10 parts by weight of achyranthes bidentata, 9 to 11 parts by weight of trillium, 5 to 8 parts by weight of cassia twig, 9 to 13 parts by weight of stir-fried cyperus rotundus, 9 to 11 parts by weight of earthworm, 9 to 11 parts by weight of borneol, 2 to 4 parts by weight of musk, and 19 to 23 parts by weight of wormwood.

3. A process for preparing a drug for regulating the urinary system according to claim 1, characterized in that: The following steps are involved: Step 1: Screen the mugwort leaves, remove impurities, thick stems and dust, and then beat and grind them in a stone trough to make them into cotton-like pieces; Step 2, sieving the cotton-like wormwood leaves in step 1 to obtain wormwood fluff; Step 3, sieving and grinding the Chinese angelica, peach kernel, roasted pangolin, zedoaria, peony bark, tuckahoe, selfheal, Achyranthes bidentata, Tripterygium wilfordii, cassia twig, stir-fried Vaccaria segetalis, Eupolyphaga sinensis, borneol, and musk into powder; Step 4: fully mix the moxa in step 2 and the medicinal powder in step 3, then add a binder and stir thoroughly to mix. After stirring and mixing, use a plodder to roll it into a cylindrical shape and wrap and fix it with mulberry bark.

4. The process for preparing a drug for regulating the urinary system according to claim 3, characterized in that: The pounding and grinding time in step 1 is 20 minutes, the pounding speed is 65 to 70 times per minute, and the screening process in step 2 requires the use of a 150-mesh screen.

5. The process for preparing a drug for regulating the urinary system according to claim 1, characterized in that: In step 3, each raw material needs to be washed and dried, and after the preparation of the medicine powder is completed, the overall moisture content must be less than 5%.

6. The process for preparing a drug for regulating the urinary system according to claim 1, characterized in that: The stirring and mixing step in step 4 needs to be equipped with a heating device to maintain the temperature in the mixing and stirring device at 50° C., so as to increase the temperature of the adhesive and avoid adhesion with the drug powder and cooling and agglomeration.